Skip to main content
. 2016 Oct 5;6(6):800–815. doi: 10.1007/s13346-016-0332-9

Table 1.

Composition of PVP-based MNs

Formulation code PVP type and concentration (%, w/w) Model drug Drug concentration in hydrogel (mg/g)
P1 PVP K29–32/30
P2 PVP K30/40
P3 PVP K15/60
F1 PVP K29–32/30 FS 2
F2 PVP K29–32/30 FD70 2
F3 PVP K29–32/30 FD150 2
F4 PVP K29–32/30 FD70 10
F5 PVP K15/60 FD70 2
F6 PVP K30/40 FD70 2